Enliven Therapeutics ELVN
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 15.40 | 115.57 | -0.48 | -34,285 | -30 | |
| 2025Q3 | 20.47 | 124.56 | -0.30 | -25,096 | -20 | |
| 2025Q2 | 20.06 | 112.82 | -0.48 | -28,584 | -25 | |
| 2025Q1 | 19.68 | 111.03 | -0.57 | -31,693 | -29 | |
| 2024Q4 | 22.50 | 116.03 | -0.46 | -26,896 | -23 | |
| 2024Q3 | 25.54 | 116.89 | -0.48 | -27,068 | -23 | |
| 2024Q2 | 23.37 | 124.77 | -0.41 | -24,603 | -20 | |
| 2024Q1 | 17.59 | 114.29 | -0.54 | -25,987 | -23 | |
| 2023Q4 | 13.84 | 117.34 | -0.46 | -22,729 | -19 | |
| 2023Q3 | 13.66 | 116.75 | -0.50 | -24,248 | -21 | |
| 2023Q2 | 20.41 | 120.41 | -0.25 | -20,134 | -17 | |
| 2023Q1 | 21.90 | 111.51 | -0.80 | -16,418 | -15 | |
| 2022Q4 | 16.36 | -19.00 | -2.90 | -5,642 | 30 | |
| 2022Q3 | 9.12 | 101.37 | -3.28 | -13,319 | -13 | |
| 2022Q2 | 4.88 | 100.49 | -2.86 | -17,504 | -17 | |
| 2022Q1 | 7.52 | 100.15 | -3.01 | -14,661 | -15 | |
| 2021Q4 | 9.00 | -2.12 | -8,395 | -8 |